Ignite Creation Date:
2024-05-05 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00381732
Status:
COMPLETED
Last Update Posted:
2007-11-07
First Post:
2006-09-26
Brief Title:
A Study to Evaluate the Efficacy and Safety of 25mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Study Overview
Official Title:
A Randomized Double-Blind Parallel Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tadalafil 25mg and 5mg Administered Once Daily to Men With Erectile Dysfunction
Status:
COMPLETED
Status Verified Date:
2007-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multicenter randomized double blind placebo-controlled parallel design study to evaluate the efficacy and safety of 25mg and 5mg tadalafil taken once daily in men with erectile dysfunction
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| H6D-MC-LVFP | None | None | None |